Effects of menopausal status on circulating calcitonin gene-related peptide and adipokines: implications for insulin resistance and cardiovascular risks

References

• Gordon T, Kannel W B, Hjortland M C, et al. Menopause and coronary heart disease: the Framingham study. Ann Intern Med 1978; 89: 157–161
   PubMed Web of Science ®Google Scholar
• Stevenson J C, Crook D, Godsland I F. Influence of age and menopause on serum lipids and lipoproteins in healthy women. Atherosclerosis 1993; 98: 83–90
   PubMed Web of Science ®Google Scholar
• Manson J E, Hsia J, Johnson K C, et al. Women's Health Initiative Investigators. Estrogen plus progestin and the risk of coronary heart disease. N Engl J Med 2003; 349: 523–534
   PubMed Web of Science ®Google Scholar
• Grady D, Herrington D, Bittener V, et al. HERS Research Group. Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERII). JAMA 2002; 288: 49–57
   PubMed Web of Science ®Google Scholar
• Watson R E, Supowit S C, Zhao H, et al. Role of sensory nervous system vasoactive peptides in hypertension. Braz J Med Biol Res 2002; 35: 1033–1045
   PubMed Web of Science ®Google Scholar
• Madeddu P, Emanueli C, Bonaria S M, et al. Role of calcitonin gene-related peptide and kinins in post-ischemic intestinal reperfusion. Peptides 2001; 22: 915–922
   PubMed Web of Science ®Google Scholar
• Chu D Q, Choy M, Foster P, et al. A comparative study of the ability of calcitonin gene-related peptide, and adrenomedullin (13-52) to modulate microvascular but not thermal hyperalgesia responses. Br J Pharmocol 2000; 130: 1589–1596
   PubMed Web of Science ®Google Scholar
• Hsu J H, Yeh J L, Dai Z K, et al. Increased circulating calcitonin gene-related peptide in congestive heart failure caused by congenital heart disease. Int Heart J 2005; 46: 867–875
   PubMed Web of Science ®Google Scholar
• Chen J T, Hirai Y, Seimiya Y. Menopausal flushes and calcitonin-gene-related peptide. Lancet 1993; 342: 49
   PubMed Web of Science ®Google Scholar
• Wyon Y, Spetz A E, Theodorsson G E, Hammar M L. Concentration of calcitonin gene-related peptide and neuropeptide Y in plasma increases during flushes in postmenopausal women. Menopause 2000; 7: 25–30
   PubMed Web of Science ®Google Scholar
• Spetz A E, Pettersson B, Varenhorst E, Theodorsson E, Thorell L H, Hammar M L. Momentary increase in plasma calcitonin gene related peptide is involved in hot flashes in men treated with castration for carcinoma of the prostate. J Urol 2001; 166: 1720–1723
   PubMed Web of Science ®Google Scholar
• Gupta P, Harte A L, da Silva N F, et al. Expression of calcitonin gene-related peptide, adrenomedullin, and receptor modifying proteins in human adipose tissue and alteration in their expression with menopause status. Menopause 2007; 14: 1031–1038
   PubMed Web of Science ®Google Scholar
• Pardutz A, Multon S, Malgrange B, et al. Effect of systemic nitroglycerin on CGRP and 5-HT afferents to rat caudal spinal trigeminal nucleus and its modulation by estrogen. Eur J Neurosci 2002; 15: 1803–1809
   PubMed Web of Science ®Google Scholar
• Moussaoul S, Duval P, Lenoir V, et al. CGRP in trigeminal nucleus, spinal cord and hypothalamus: effect of gonadal steroids. Neuropeptides 1996; 30: 546–550
   PubMed Web of Science ®Google Scholar
• Berg A H, Scherer P E. Adipose tissue, inflammation and cardiovascular disease. Circ Res 2005; 96: 939–949
   PubMed Web of Science ®Google Scholar
• Silha J V, Krsek M, Skrha J V, et al. Plasma resistin, adiponectin and leptin levels in lean and obese subjects: correlations with insulin resistance. Eur J Endocrinol 2003; 149: 331–335
   PubMed Web of Science ®Google Scholar
• Baratta R, Amato S, Degano C, et al. Adiponectin relationship with lipid metabolism is independent of body fat mass: evidence from both cross-sectional and intervention studies. J Clin Endocrinol Metab 2004; 89: 2665–2671
   PubMed Web of Science ®Google Scholar
• Rosenbaum M, Nicolson M, Hirsch J, et al. Effects of gender, body composition, and menopause on plasma concentrations of leptin. J Clin Endocrinol Metab 1996; 81: 3424–3427
   PubMed Web of Science ®Google Scholar
• Gavrila A, Chan J L, Yiannakouris N, et al. Serum adiponectin levels are inversely associated with overall and central fat distribution but are not directly regulated by acute fasting or leptin administration in humans: cross-sectional and interventional studies. J Clin Endocrinol Metab 2003; 88: 4823–4831
   PubMed Web of Science ®Google Scholar
• Milewicz A, Zatonska K, Demissie M, et al. Serum adiponectin concentration and cardiovascular risk factors in climacteric women. Gyecol Endocrinol 2005; 20: 68–73
   PubMed Web of Science ®Google Scholar
• Kusminski C M, McTernan P G, Kumar S. Role of resistin in obesity, insulin resistance and type II diabetes. Clin Sci 2005; 109: 243–256
   PubMed Web of Science ®Google Scholar
• Vendrell J, Broch M, Vilarrasa N, et al. Resistin, adiponectin, ghrelin, leptin, and proinflammatory cytokines: relationships in obesity. Obes Res 2004; 12: 962–971
   PubMedGoogle Scholar
• Singhal A, Farooqi I S, Cole T J, et al. Influence of leptin on arterial distensibility: a novel link between obesity and cardiovascular disease?. Circulation 2002; 106: 1919–1924
   PubMed Web of Science ®Google Scholar
• Konstantinides S, Schafer K, Loskutoff D J. The prothrombotic effects of leptin possible implications for the risk of cardiovascular disease in obesity. Ann N Y Acad Sci 2001; 947: 134–141
   PubMed Web of Science ®Google Scholar
• Xu F P, Chen M S, Wang Y Z, et al. Leptin induces hypertrophy via endothelin-1-reactive oxygen species pathway in cultured neonatal rat cardiomyocytes. Circulation 2004; 110: 1269–1275
   PubMed Web of Science ®Google Scholar
• Singhal A, Jamieson N, Fewtrell M, et al. Adiponectin predicts insulin resistance but not endothelial function in young, healthy adolescents. J Clin Endocrinol Metab 2005; 90: 4615–4621
   PubMed Web of Science ®Google Scholar
• Pilz S, Maerz W, Weihrauch G, et al. Adiponectin serum concentrations in men with coronary artery disease: The Ludwigshafen Risk in cardiovascular Health (LURIC) study. Clin Chim Acta 2006; 364: 251–255
   PubMed Web of Science ®Google Scholar
• Hansson G K. Inflammation. Atherosclerosis, and coronary artery disease. N Engl J Med 2005; 352: 1685–1695
   PubMed Web of Science ®Google Scholar
• Margolis K L, Manson J E, Greenland P, et al. Women's Health Initiative Research Group. Leukocytes count as a predictor of cardiovascular events and mortality in postmenopausal women: the Women's Health Initiative Observational Study. Arch Intern Med 2005; 165: 500–508
   PubMed Web of Science ®Google Scholar
• Choi S B, Frontoni S, Rossetti L. Mechanism by which calcitonin gene-related peptide antagonizes insulin action in vivo. Am J Physiol 1991; 260: E321–E325
   PubMed Web of Science ®Google Scholar
• Wyon Y, Spetz A E, Theodorsson G E, et al. Concentration of calcitonin gene-related peptide and neuropeptide Y in plasma increases during flushes in postmenopausal women. Menopause 2000; 7: 25–30
   PubMed Web of Science ®Google Scholar
• Valentini A, Petraglia F, Vita D D, et al. Changes of plasma calcitonin gene-related peptide levels in postmenopausal women. Am J Obstet Gynecol 1996; 173: 638–642
   Google Scholar
• McKinlay S M, Jefferys M. The menopausal syndrome. Br J Prevent Soc Med 1974; 28: 108–115
   PubMedGoogle Scholar
• Le Greves P, Nyberg F, Hokfelt T, et al. Calcitonin gene-related peptide is metabolized by an endopeptidase hydrolyzing substance P. Regul Pept 1989; 25: 277–286
   PubMed Web of Science ®Google Scholar
• Simpson E, Rubin G, Clyne C, et al. Local estrogen biosynthesis in males and females. Endocr Relat Cancer 1999; 6: 131–137
   PubMed Web of Science ®Google Scholar
• Gallicchio L, Visvanathan K, Miller S R, et al. Body mass, estrogen levels, and hot flashes in midlife women. Am J Obstet Gynecol 2005; 193: 1353–1360
   PubMed Web of Science ®Google Scholar
• Kotani K, Tokunaga K, Fujioka S, et al. Sexual dimorphism of age-related changes in whole-body fat distribution in the obese. Int J Obes Relat Metab Disord 1994; 18: 207
   PubMed Web of Science ®Google Scholar
• Matthews K A, Meilahn E, Kuller L H, et al. Menopause and risk factors for coronary heart disease. N Engl J Med 1989; 321: 641–646
   PubMed Web of Science ®Google Scholar